Roth Capital Trims PT on Celldex (CLDX) to $39 Following Q2 Results; Would be Buyers on Weakness

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. KBH
3. FDX
4. HON
5. HTZ
6. TTWO
7. QCOM
8. HONA
9. USO
10. HELP

Go back to Roth Capital Trims PT on Celldex (CLDX) to $39 Following Q2 Results; Would be Buyers on Weakness

Form 10-Q Celldex Therapeutics, For: Jun 30

August 10, 2015 4:29 PM EDT

Table of Contents

 

 

 

... More